Reduced Salivary Lactoferrin Levels in Early-Onset Alzheimer's Disease

Affiliations

• ¹ Neurobiology of Alzheimer's disease Unit, Functional Unit for Research into Chronic Diseases, Instituto de Salud Carlos III, Madrid, Spain; Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), ISCIII, Spain.
• ² Group of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), Madrid, Spain; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), ISCIII, Spain.
• ³ Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville, Spain; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), ISCIII, Spain.
• ⁴ Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria, Spain; Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain; Networking Center for Biomedical Research in Bioengineering Biomaterials and Nanomedicine (CIBER-BBN), ISCIII, Spain.